1-(3-chlorophenyl)piperazine has been researched along with triazolam in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Delatte, MS; McCann, UD; Moerschbaecher, JM; Ricaurte, GA; Stevenson, MW; Winsauer, PJ; Yuan, J | 1 |
2 other study(ies) available for 1-(3-chlorophenyl)piperazine and triazolam
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Effects of fenfluramine, m-CPP and triazolam on repeated-acquisition in squirrel monkeys before and after neurotoxic MDMA administration.
Topics: Animals; Behavior, Animal; Brain; Dose-Response Relationship, Drug; Fenfluramine; GABA Modulators; Hydroxyindoleacetic Acid; Learning; N-Methyl-3,4-methylenedioxyamphetamine; Piperazines; Reaction Time; Saimiri; Serotonin; Serotonin Agents; Serotonin Receptor Agonists; Triazolam | 2002 |